세계의 조직 은행 시장 예측(2025-2030년)

The tissue banking market is expected to grow from USD 2.128 billion in 2025 to USD 3.286 billion in 2030, at a CAGR of 9.07%.

The global tissue banking market is experiencing significant growth, driven by increasing demand for fresh specimens and tissues in medical and research applications. Tissue banks, which collect and store biological specimens for future use, are pivotal in supporting advancements in healthcare and research, particularly in the treatment of chronic diseases and tissue regeneration. This summary highlights key growth drivers and geographical trends based on market developments from 2024 onward, tailored for industry experts.

Market Growth Drivers

Rising Demand for Tissue in Chronic Disease Treatment

The escalating need for tissues to treat chronic conditions, such as cancer, is a primary driver of the global tissue banking market. Tissue banks provide critical specimens used in regenerative therapies, addressing the growing prevalence of chronic disorders. In the United States, the tissue banking network is robust, with approximately 58 accredited tissue banks, as reported by the American Association of Tissue Banks (AATB). These banks are certified by the U.S. Food and Drug Administration (FDA), ensuring compliance with stringent regulatory standards. Blood tissues and cells dominate the market, reflecting their critical role in regenerative treatments. Government support, particularly in the U.S., further accelerates market expansion by promoting tissue bank utilization in healthcare.

Advancements in Research and Development

The surge in research and development (R&D) activities focused on tissue regeneration and chronic disease treatment is propelling the tissue banking market forward. Innovations, such as stem cell applications for developing various tissues, represent significant breakthroughs in the medical and health research sectors. Major industry players, including Allergan and Hamilton Companies, are investing heavily in tissue engineering, enhancing the development and application of tissue-based therapies. These R&D efforts are expanding the scope of tissue banks, enabling them to meet the growing demand for advanced therapeutic solutions and driving market growth.

Geographical Outlook

North America's Dominant Market Share

North America holds the largest share of the global tissue banking market, driven by a well-established network of tissue banks and robust R&D in tissue engineering. The region benefits from the presence of leading market players and a high incidence of chronic diseases, which increase the demand for tissue-based treatments. The U.S., in particular, leads due to its advanced healthcare infrastructure, FDA-accredited tissue banks, and supportive government policies. These factors collectively position North America as the epicenter of tissue banking innovation and market growth.

Conclusion

The global tissue banking market is poised for continued expansion, fueled by the rising need for tissues in chronic disease treatment and advancements in tissue engineering research. North America remains the market leader, supported by a strong network of accredited tissue banks and significant investments from key players. As the medical and research sectors increasingly rely on tissue banks, the market is expected to maintain its growth trajectory, offering substantial opportunities for stakeholders in the healthcare and biotechnology industries.

Key Benefits of this Report:

• Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
• Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
• Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
• Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
• Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

• Historical data from 2022 to 2024 & forecast data from 2025 to 2030
• Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
• Competitive Positioning, Strategies, and Market Share Analysis
• Revenue Growth and Forecast Assessment of segments and regions including countries

Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.

Tissue Banking Market Segmentation

By Tissue Type

• Cornea
• Skin
• Bones
• Heart Valves
• Others

By Storage Type

• Cryopreservation
• Deep-Freezing
• Others

By Application

• Therapeutic
• Research & Development
• Tissue Engineering
• Others

By End-User

• Hospitals
• Research & Academic Institutes
• Others

By Geography

• North America
• USA
• Canada
• Mexico
• South America
• Brazil
• Argentina
• Others
• Europe
• Germany
• France
• UK
• Others
• Middle East and Africa
• Saudi Arabia
• UAE
• Others
• Asia Pacific
• China
• India
• Japan
• South Korea
• Taiwan
• Thailand
• Indonesia
• Others

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

• 2.1. Market Overview
• 2.2. Market Definition
• 2.3. Scope of the Study
• 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

• 3.1. Market Drivers
• 3.2. Market Restraints
• 3.3. Market Opportunities
• 3.4. Porter's Five Forces Analysis
• 3.5. Industry Value Chain Analysis
• 3.6. Policies and Regulations
• 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. TISSUE BANKING MARKET BY TISSUE TYPE

• 5.1. Introduction
• 5.2. Cornea
• 5.3. Skin
• 5.4. Bones
• 5.5. Heart Valves
• 5.6. Others

6. TISSUE BANKING MARKET BY STORAGE TYPE

• 6.1. Introduction
• 6.2. Cryopreservation
• 6.3. Deep-Freezing
• 6.4. Others

7. TISSUE BANKING MARKET BY APPLICATION

• 7.1. Introduction
• 7.2. Therapeutic
• 7.3. Research & Development
• 7.4. Tissue Engineering
• 7.5. Others

8. TISSUE BANKING MARKET BY END-USER

• 8.1. Introduction
• 8.2. Hospitals
• 8.3. Research & Academic Institutes
• 8.4. Others

9. TISSUE BANKING MARKET BY GEOGRAPHY

• 9.1. Introduction
• 9.2. North America
  • 9.2.1. USA
  • 9.2.2. Canada
  • 9.2.3. Mexico
• 9.3. South America
  • 9.3.1. Brazil
  • 9.3.2. Argentina
  • 9.3.3. Others
• 9.4. Europe
  • 9.4.1. Germany
  • 9.4.2. France
  • 9.4.3. United Kingdom
  • 9.4.4. Spain
  • 9.4.5. Others
• 9.5. Middle East and Africa
  • 9.5.1. Saudi Arabia
  • 9.5.2. UAE
  • 9.5.3. Others
• 9.6. Asia Pacific
  • 9.6.1. China
  • 9.6.2. India
  • 9.6.3. Japan
  • 9.6.4. South Korea
  • 9.6.5. Indonesia
  • 9.6.6. Others

10. COMPETITIVE ENVIRONMENT AND ANALYSIS

• 10.1. Major Players and Strategy Analysis
• 10.2. Market Share Analysis
• 10.3. Mergers, Acquisitions, Agreements, and Collaborations
• 10.4. Competitive Dashboard

11. COMPANY PROFILES

• 11.1. Life Link Tissue Bank
• 11.2. Alamo Biologics
• 11.3. ViaCord (Revvity Inc.)
• 11.4. DCI Donor Services Tissue Bank
• 11.5. Thermo Fisher Scientific Inc.
• 11.6. Azenta Life Sciences
• 11.7. Tecan Group Ltd.
• 11.8. BioLife Solutions, Inc.
• 11.9. PHC Corporation
• 11.10. Rokit Healthcare

12. APPENDIX

• 12.1. Currency
• 12.2. Assumptions
• 12.3. Base and Forecast Years Timeline
• 12.4. Key benefits for the stakeholders
• 12.5. Research Methodology
• 12.6. Abbreviations